Clinical Trial Update: Combination Study of Guadecitabine/ASTX727 and Pembrolizumab [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of combining guadecitabine and ASTX727 with pembrolizumab in non-small cell lung cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ASTX727 (cedazuridine/decitabine)
• Guadecitabine (guadecitabine)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING